Adam Maeder Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Adam Maeder

Stock Analyst at Piper Sandler

(3.7)
# 2391
Out of 5,493 analysts
146
Total ratings
Success rate
Average return

22 Stocks

Name Action PT Current % Upside Ratings Updated
RBOT Vicarious Surgical
Maintains: Neutral
9 7
5.41 29.39% 8 Aug 13, 2025
INSP Inspire Medical Syst...
Maintains: Overweight
233 150
77.23 94.23% 15 Aug 5, 2025
RMD ResMed
Maintains: Neutral
248 270
270.31 -0.11% 4 Aug 1, 2025
EW Edwards Lifesciences
Maintains: Overweight
83 90
76.27 18% 16 Jul 25, 2025
ISRG Intuitive Surgical
Reiterates: Overweight
575 595
441.12 34.88% 20 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 10
9.03 10.74% 2 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
3.48 14.94% 1 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 4
2.4 66.67% 4 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 14
13.78 1.6% 3 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
133 145
133.57 8.56% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 6
n/a n/a 16 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 80
n/a n/a 7 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
18 16.67% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
n/a n/a 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
n/a n/a 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
2.71 195.2% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
4.45 349.44% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.92 71.23% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
1.45 1141.38% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
53.44 85.25% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
n/a n/a 5 Jun 14, 2021